Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT00601003
Title Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Giselle Sholler
Indications
Therapies
Age Groups: adult | child
Covered Countries USA


No variant requirements are available.